Visit-to-visit blood pressure variability and cardiovascular outcomes: a systematic review and dose-response meta-analysis

• by Mifetika Lukitasari, Jitendra Jonnagaddala, Siaw-Teng Liaw, Bin Jalaludin

• August 28, 2025

Performance of large language models in delivering accurate and comprehensible patient information on heart failure and cardiomyopathy

• by Christoph Reich, Jule Leverenz, Charlotte Brand, Lasse Niemeier, Isabel Branzei, Mustafa Yildirim, Farbod Sedaghat-Hamedani, Ali Amr, Norbert Frey, Benjamin Meder

• June 9, 2026

Lung ultrasound B-lines, NT-proBNP, and left atrial volume Index for bedside characterization of preserved-ejection-fraction phenotype in acute heart failure: a single-center observational study

• by Bin Peng, Yanxia Zhang

• June 5, 2026

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

• by Andrea Surnit

• June 10, 2026

• 4 min